NeoTract Announces Japanese Regulatory Approval for UroLift® System for Treatment of Enlarged Prostate
November 5, 2018
PLEASANTON, Calif. – November 5, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in...
Read MoreNeoTract Receives Phoenix 2018 Emerging Growth Company Award for Outstanding Industry Achievement
October 29, 2018
PLEASANTON, Calif. – October 29, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in...
Read MoreNeoTract Announces Data from New Real-World Study Demonstrating Excellent Results for UroLift® System Treatment for Enlarged Prostate
October 15, 2018
PLEASANTON, Calif. – Oct. 15, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the...
Read MoreNeoTract Announces Results from Five Real-World Studies Reaffirming Efficacy and Safety of UroLift® System Treatment for Enlarged Prostate
September 24, 2018
PLEASANTON, Calif. – Sept. 24, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in...
Read MoreNeoTract Announces Multiple Data Presentations from Studies of UroLift® System Treatment for Enlarged Prostate at the World Congress of Endourology
September 18, 2018
PLEASANTON, Calif. – Sept. 17, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in...
Read MoreNeoTract Announces Independent Analysis in UK Confirming Cost Effectiveness of UroLift® System Treatment for Benign Prostatic Hyperplasia (BPH)
June 8, 2018
WAYNE, PA – June 08, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of...
Read MoreNeoTract Announces American Urological Association (AUA) Recommendation of UroLift® System as a Standard of Care Option for the Treatment of Enlarged Prostate
May 18, 2018
PLEASANTON, Calif. – May 18, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE: TFX) focused on addressing unmet needs in the...
Read MoreNeoTract To Unveil New Clinical Data on the UroLift® System at American Urological Association 2018 Meeting
May 16, 2018
PLEASANTON, Calif. - May 16, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the...
Read MoreNeoTract Announces Data from Large Real-World Study of UroLift® System, Confirming Positive Results for Company’s Treatment for Enlarged Prostate
March 20, 2018
PLEASANTON, Calif. – March 19, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE: TFX) focused on addressing unmet needs in...
Read MoreTeleflex Incorporated Completes Acquisition of Neotract
October 2, 2017
Contact: Jake Elguicze Treasurer and Vice President of Investor Relations 610-948-2836
Read More
